Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 2;22(1):14.
doi: 10.1186/s12913-021-07411-2.

What do health professionals need to know about young onset dementia? An international Delphi consensus study

Affiliations

What do health professionals need to know about young onset dementia? An international Delphi consensus study

Leah Couzner et al. BMC Health Serv Res. .

Abstract

Background: People with young onset dementia (YOD) have unique needs and experiences, requiring care and support that is timely, appropriate and accessible. This relies on health professionals possessing sufficient knowledge about YOD. This study aims to establish a consensus among YOD experts about the information that is essential for health professionals to know about YOD.

Methods: An international Delphi study was conducted using an online survey platform with a panel of experts (n = 19) on YOD. In round 1 the panel individually responded to open-ended questions about key facts that are essential for health professionals to understand about YOD. In rounds 2 and 3, the panel individually rated the collated responses in terms of their importance in addition to selected items from the Dementia Knowledge Assessment Scale. The consensus level reached for each statement was calculated using the median, interquartile range and percentage of panel members who rated the statement at the highest level of importance.

Results: The panel of experts were mostly current or retired clinicians (57%, n = 16). Their roles included neurologist, psychiatrist and neuropsychiatrist, psychologist, neuropsychologist and geropsychologist, physician, social worker and nurse practitioner. The remaining respondents had backgrounds in academia, advocacy, or other areas such as law, administration, homecare or were unemployed. The panel reached a high to very high consensus on 42 (72%) statements that they considered to be important for health professionals to know when providing care and services to people with YOD and their support persons. Importantly the panel agreed that health professionals should be aware that people with YOD require age-appropriate care programs and accommodation options that take a whole-family approach. In terms of identifying YOD, the panel agreed that it was important for health professionals to know that YOD is aetiologically diverse, distinct from a mental illness, and has a combination of genetic and non-genetic contributing factors. The panel highlighted the importance of health professionals understanding the need for specialised, multidisciplinary services both in terms of diagnosing YOD and in providing ongoing support. The panel also agreed that health professionals be aware of the importance of psychosocial support and non-pharmacological interventions to manage neuropsychiatric symptoms.

Conclusions: The expert panel identified information that they deem essential for health professionals to know about YOD. There was agreement across all thematic categories, indicating the importance of broad professional knowledge related to YOD identification, diagnosis, treatment, and ongoing care. The findings of this study are not only applicable to the delivery of support and care services for people with YOD and their support persons, but also to inform the design of educational resources for health professionals who are not experts in YOD.

Keywords: Consensus; Delphi study; Health professionals; Knowledge; Young onset dementia.

PubMed Disclaimer

Conflict of interest statement

MC has been employed in the past 5 years to assist with data collection for Alzheimer’s disease drug trials funded by Janssen and Merck. All other authors declare no conflicts of interest.

Similar articles

Cited by

References

    1. Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M, et al. World Alzheimer Report 2015: The global impact of dementia: An analysis of prevalence, incidence, cost and trends. 2015 [cited 2021 Mar 24]; Available from: https://www.alzint.org/resource/world-alzheimer-report-2015/
    1. Mayrhofer A, Shora S, Tibbs M-A, Russell S, Littlechild B, Goodman C. Living with young onset dementia: reflections on recent developments, current discourse, and implications for policy and practice. Ageing Society. 2020:1–9.
    1. Cations M, Withall A, Horsfall R, Denham N, White F, Trollor J, et al. Why aren’t people with young onset dementia and their supporters using formal services? Results from the INSPIRED study. PLoS One. 2017;12(7):e0180935. doi: 10.1371/journal.pone.0180935. - DOI - PMC - PubMed
    1. Sansoni J, Duncan C, Grootemaat P, Capell J, Samsa P, Westera A. Younger onset dementia: a review of the literature to inform service development. Am J Alzheimers Dis Other Demen. 2016;31(8):693–705. doi: 10.1177/1533317515619481. - DOI - PMC - PubMed
    1. Roach P, Drummond N, Keady J. ‘Nobody would say that it is Alzheimer’s or dementia at this age’: family adjustment following a diagnosis of early-onset dementia. J Aging Stud. 2016;36:26–32. doi: 10.1016/j.jaging.2015.12.001. - DOI - PubMed